home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

232 rows where filing_period = "second_quarter", filing_year = 2014 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 232 ✖

filing_year 1

  • 2014 · 232 ✖

filing_period 1

  • second_quarter · 232 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1545240 INDEPENDENT PHARMACY COOPERATIVE 2b0ccfe9-2ffa-4dd0-a2fb-259fd67d3ace Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2014 second_quarter PHA CMS Proposed Program Changes for Medicare Advantage and Prescription Drug Benefit Program for Conract Year 2015-Support Changes to Preferred Networks, Mail Order Prescriptions and MTM Services. Centers For Medicare and Medicaid Services (CMS),SENATE     0 0 2014-06-13T11:58:48.320000-04:00
1545762 CYBER SECURITY RESEARCH CONSULTANTS, LLC 66b00f97-0826-4463-aa77-ac3d0a6c8b2d Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2014 second_quarter PHA Monitoring Drug importation legislation FY 15 Agriculture Appropriations Bill HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-07-02T09:05:12.983000-04:00
1545812 INJURED WORKERS PHARMACY a33a19f4-9fe1-41db-8f56-345da0c8904d Q2 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2014 second_quarter PHA n/a HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-07-02T11:51:42.200000-04:00
1545835 CHAMBER HILL STRATEGIES 65a2174b-c80e-49ae-a089-d2cb12af6016 Q2 CHAMBER HILL STRATEGIES 400645947 AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) 2014 second_quarter PHA Implementation issues related to P.L. 113-54, the Drug Quality and Security Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-07-02T13:00:18.497000-04:00
1546092 GOVBIZ ADVANTAGE, INC. abdd4201-a325-4274-8379-efc95603e7ce Q2 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2014 second_quarter PHA Monitor Pharmacy Benefit Issues; select state delegation outreach HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-03T14:55:36.113000-04:00
1546102 GOVBIZ ADVANTAGE, INC. b55119be-ff56-49ed-809e-0f6190659492 Q2 GOVBIZ ADVANTAGE, INC. 294234 WHITE HOUSE CONSULTING (FOR SYMBIOMIX) 2014 second_quarter PHA Womens health issues and GAIN Act implementation issues HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-03T15:20:43.307000-04:00
1546313 RED+BLUE STRATEGIES 24b1f6af-6bda-42b8-911d-3f58c014f2dc Q2 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2014 second_quarter PHA Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for individuals with pain management needs. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-07T11:35:30.300000-04:00
1546516 UNIVERSITY OF IOWA cf181ad3-9e3c-4fde-b44d-3554ff1d2ae6 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2014 second_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   85562 0 0 2014-07-07T14:28:39.173000-04:00
1546583 RED+BLUE STRATEGIES 0354785d-fe5d-46b7-8a16-220ad90c3912 Q2 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2014 second_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Issues regarding prescription drug coverage for DoD Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-07T16:20:17.773000-04:00
1546591 MR. THEODORE (TED) JONES 4000100e-f835-4ad3-b5d9-a00666e5a8ed Q2 MR. THEODORE (TED) JONES 20926 COQUI RADIOPHARMACEUTICALS, CORP. 2014 second_quarter PHA American Medical Isotopes Production Act of 2012 that was contained in the National Defense Authorization Act for Fiscal Year 2013. Acceleration of production on 99 MO using LEU (Low Enriched Uranium). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-07T16:30:20.033000-04:00
1546599 HANCE SCARBOROUGH 127570d9-1662-4eaa-ad4e-bd1dcbe27fee Q2 HANCE SCARBOROUGH 17443 ALLIANCE OF INDEPENDENT PHARMACISTS - TEXAS 2014 second_quarter PHA Federal legislation affecting the practice of pharmacy, and FDA and DEA regulations of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-07T17:22:26.387000-04:00
1546622 MR. JOHN COSTER 0c3f9a4b-8457-42da-9ad1-872e10656788 Q2 MR. JOHN COSTER 401103305 AMERISOURCE BERGEN 2014 second_quarter PHA H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014; H.R. 800, S. 806, Excluding Customary Prompt Pay Discounts from ASP in calculating Medicare Part B   10000   0 0 2014-07-07T22:28:22.473000-04:00
1546823 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE f03ee5d1-e6d8-4ebd-8756-81e41c340c05 2A COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 11003 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 2014 second_quarter PHA H.R. 4577, Ensuring Seniors Access to Local Pharmacies Act of 2014, all sections HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2014-07-08T12:38:10.107000-04:00
1547008 CAPITOL HILL CONSULTING GROUP f6104c3b-43e6-46db-a54a-5353cae18279 Q2 CAPITOL HILL CONSULTING GROUP 72053 WELLNESS PHARMACY 2014 second_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-08T16:19:28.337000-04:00
1547010 CAPITOL HILL CONSULTING GROUP 2cefd209-9f33-4cf4-a39d-ac7a8f2ffbf4 Q2 CAPITOL HILL CONSULTING GROUP 72053 ROCK & ASSOCIATES 2014 second_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-08T16:24:29.663000-04:00
1547017 CAPITOL HILL CONSULTING GROUP a8fdbd38-28f6-4f37-9d77-9294a9b30102 Q2 CAPITOL HILL CONSULTING GROUP 72053 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2014 second_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-08T16:37:33.203000-04:00
1547036 CAPITOL HILL CONSULTING GROUP b7fe7be0-7c25-42f3-94e6-cc8b9a7146b4 Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2014 second_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-08T16:53:38.713000-04:00
1547136 MR. JOHN COSTER 6bc802a2-3f48-4814-94e0-08588d565a2c Q2 MR. JOHN COSTER 401103305 AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS 2014 second_quarter PHA Pharmacy Provider Status issues, particularly H.R. 4190, Medicare Coverage of Pharmacy Services       0 0 2014-07-09T07:31:38.353000-04:00
1547193 MR. VINCENT A. PANVINI 37403ab7-d02c-4bf6-82eb-5262fbd2e5c7 Q2 MR. VINCENT A. PANVINI 401008845 PHRMA 2014 second_quarter PHA Transpacific Partnership, Patent Reform Bill HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2014-07-09T10:03:43.890000-04:00
1547370 SQUIRE PATTON BOGGS e4d5f5ca-3b99-4ae9-a7d7-a611ee263a70 2T SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2014 second_quarter PHA S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013. HOUSE OF REPRESENTATIVES,SENATE 120000   0 1 2014-07-09T13:49:04.537000-04:00
1547409 ABRAHAM & ROETZEL, LLC 72a7843e-fb42-461c-89de-0448c6f9fac7 Q2 ABRAHAM & ROETZEL, LLC 400954757 MATCHRX 2014 second_quarter PHA Drug Quality and Security Act. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-09T14:26:21.553000-04:00
1547449 KATE MOSS 5d58ccaf-b364-44e9-a6f5-6663deeebc1b Q2 KATE MOSS 25988 CVS HEALTH 2014 second_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-07-09T15:29:05.340000-04:00
1547519 SANOFI US SERVICES INC. a053668b-7c72-430a-9dc5-46e515a03fcd Q2 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2014 second_quarter PHA General issues related to the 340B Federal Drug Pricing Program HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   720000 0 0 2014-07-09T17:05:11.757000-04:00
1547664 THE MATHIS HARPLE GROUP f2f9add9-5437-49b2-801a-621be58343a6 Q2 THE MATHIS HARPLE GROUP 322911 PILMA 2014 second_quarter PHA Patent Reform Legislation, Transpacific Partnership, Intellectual Property HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2014-07-10T11:12:50.473000-04:00
1548006 ROCK & ASSOCIATES 0472fea7-06f4-47d8-a747-ecd3d2c6c509 Q2 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2014 second_quarter PHA Legislation affecting the operation compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-10T16:51:03.713000-04:00
1548202 MR. JOHN COSTER fe6b5ecc-dfcd-41ee-bbd1-d6f9c6188aca Q2 MR. JOHN COSTER 401103305 HORIZON GOVERNMENT AFFAIRS 2014 second_quarter PHA medication therapy management legislation, HR 1024, S. 557   5000   0 0 2014-07-10T20:00:13.813000-04:00
1548289 DICKSTEIN SHAPIRO LLP bf5a2166-d07b-4b22-ab93-b7dfb728574a Q2 DICKSTEIN SHAPIRO LLP 12208 VERIMED, LLC 2014 second_quarter PHA Monitor legislative and administrative action regarding prescription drug abuse and diversion policies. H.R. 4486, Military Construction Veterans Affairs and Related Agencies Appropriations Act, 2015. Draft, Senate Military Construction Veterans Affairs and Related Agencies Appropriations Act, 2015. S. 2450, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014. Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 60000   0 0 2014-07-10T23:05:28.883000-04:00
1548444 VALENTE & ASSOCIATES 98aeaca6-c45c-439a-bd48-0120f85898f4 Q2 VALENTE & ASSOCIATES 45983 SAV-MOR FRANCHISING, INC. 2014 second_quarter PHA Medicare Part D HOUSE OF REPRESENTATIVES     0 0 2014-07-11T10:01:34.217000-04:00
1548896 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c47d5500-afee-49ff-a410-5ed7be5841f7 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2014 second_quarter PHA Issues related to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-11T14:51:11.887000-04:00
1548908 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c8f0c9ac-a393-4b93-aced-fa35635e3799 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2014 second_quarter PHA HR 460 Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S 1879 Cancer Treatment Parity Act. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2014-07-11T14:58:19.353000-04:00
1548923 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 6b4e13a8-8de4-4d04-86f8-3ea3b67281b0 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2014 second_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 Patients Access to Treatment Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2014-07-11T15:08:25.037000-04:00
1548938 DELAHUNT GROUP, LLC c22c0b87-127f-4395-ae2a-5fba06c6dfc8 Q2 DELAHUNT GROUP, LLC 401066001 HEALIANCE PHARMACEUTICALS 2014 second_quarter PHA Issues related to issuance of supplemental OFAC license. HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS) 50000   0 0 2014-07-11T15:16:22.223000-04:00
1549016 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 14af9727-2824-4e38-89a6-ed06a53b7597 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2014 second_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2014-07-11T16:06:52.390000-04:00
1549101 PARRY, ROMANI, DECONCINI & SYMMS e0150226-eaee-483f-bc9d-c433c7141846 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2014 second_quarter PHA Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2014-07-11T17:10:25.350000-04:00
1549602 PD FRAZER CONSULTING, INC. 723885b5-08bf-4e80-b772-febd0cce0327 Q2 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2014 second_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-07-14T11:37:22.750000-04:00
1549616 RUBICON ADVISORS, LLC f3aede7a-cca7-46b8-95c3-38df79cda916 Q2 RUBICON ADVISORS, LLC 315091 STATE MUTUAL INSURANCE COMPANY 2014 second_quarter PHA Pharmacy - Compounding HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-14T11:40:03.873000-04:00
1549665 RUBICON ADVISORS, LLC bdfa6312-8440-43a6-bff6-670718121b3a Q2 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2014 second_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-14T11:49:17.497000-04:00
1549675 RUBICON ADVISORS, LLC 20ae17bb-8a88-4cfb-903d-fe5410a16809 Q2 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2014 second_quarter PHA Food and Drug Administration - Vaccines Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-07-14T11:54:23.497000-04:00
1549688 RUBICON ADVISORS, LLC ab416d5e-934a-4e51-b109-eb386d87eaf5 Q2 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2014 second_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2014-07-14T11:59:26.590000-04:00
1549693 RUBICON ADVISORS, LLC c4fe49e1-44b1-4b76-a4e8-ca1e30d99c34 Q2 RUBICON ADVISORS, LLC 315091 ALLIANCE TO PREVENT THE ABUSE OF MEDICINES 2014 second_quarter PHA Prescription Drug Abuse Police HOUSE OF REPRESENTATIVES,SENATE 52500   0 0 2014-07-14T12:04:28.137000-04:00
1550411 HEARTLAND SOLUTIONS GROUP, INC. e34a05e1-77ac-4ce5-b17b-6ff506fc423e Q2 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2014 second_quarter PHA Any and all issues related to labeling of generic drugs. HOUSE OF REPRESENTATIVES,SENATE 8950   0 0 2014-07-14T16:48:11.947000-04:00
1550521 GENENTECH, INC 674f3827-481a-4085-8bf6-36ec72dcd98e Q2 GENENTECH, INC 15920 GENENTECH INC 2014 second_quarter PHA Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies, 340(b) Drug Discount Program, Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare presciption drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010- Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - legislation related to reauthorization of user fees for prescription drug, medical device, and biologics approval. All aspects. General issues and congressional oversight related to FDA approval and CMS coverage decisions regarding Avastin and Lucentis. S. 959 - Pharmaceutical Quality, Security, and Accountability Act- legislation regarding pharmacy compounding and track and trace proposals. Public Law 113-67, Continuing Appropriations Resolution for 2014 - General public health spending. Public law 113-54- The Drug quality and Security Act - drug compounding and track trace issues. HOUSE OF REPRESENTATIVES,SENATE   836600 0 0 2014-07-14T18:24:49.397000-04:00
1550724 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING a88fec84-4c3c-407b-ab42-1377c02f06bb Q2 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2014 second_quarter PHA Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204). Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE   80000 0 0 2014-07-15T09:34:04.703000-04:00
1550824 ROCK & ASSOCIATES 567528b8-976a-4802-97ba-695902c7cb77 Q2 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-07-15T10:43:25.483000-04:00
1550851 ROCK & ASSOCIATES de516c51-3778-46b9-b8da-2a26426197e3 Q2 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-15T10:54:30.217000-04:00
1550863 FLYNN & ASSOCIATES, INC. 4f58614e-9961-47dc-9755-25fd0a05b5c5 Q2 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2014 second_quarter PHA Medicare Part-D Rebates HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-07-15T11:03:33.020000-04:00
1550876 FLYNN & ASSOCIATES, INC. 5aaac151-1086-41c0-b5bc-3b70b350d386 Q2 FLYNN & ASSOCIATES, INC. 15020 AMERICAN CHEMISTRY COUNCIL, INC. 2014 second_quarter PHA TSCA Reform S.1009 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-07-15T11:07:36.957000-04:00
1550878 ROCK & ASSOCIATES 9f90eb50-677e-4d79-aee3-47f3f493ff3c Q2 ROCK & ASSOCIATES 33545 US COMPOUNDING 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-15T11:08:38.283000-04:00
1550899 ROCK & ASSOCIATES 9481beff-d89e-4f56-8987-6c21bf8fb813 Q2 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-15T11:18:44.160000-04:00
1550920 ROCK & ASSOCIATES b2d741c2-89cb-4022-a174-50d9a4f319f4 Q2 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-15T11:27:48.083000-04:00
1550931 ROCK & ASSOCIATES 4d8779c4-6bb5-480b-bfef-d4bc4f4d6f33 Q2 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-07-15T11:36:51.330000-04:00
1550950 ROCK & ASSOCIATES 727fe420-04d3-40e9-833b-5ae215fd1f30 Q2 ROCK & ASSOCIATES 33545 TOWN & COUNTRY COMPOUNDING AND CONSULTING 2014 second_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-07-15T11:46:58.127000-04:00
1551215 THE DUBERSTEIN GROUP INC. 46d8830d-4399-4ff4-9813-6d09e2687be3 Q2 THE DUBERSTEIN GROUP INC. 12675 PFIZER INC. 2014 second_quarter PHA Agriculture appropriations re drug reimportation - HR 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015; S 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2014-07-15T14:17:24.870000-04:00
1551290 BRAVO GROUP 5b130c9b-7398-466b-bde6-7a691f51f1bf Q2 BRAVO GROUP 296293 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2014 second_quarter PHA Biopharmaceutical issues including: social and economic value of the biopharmaceutical sector, patient access and safety issues, life science innovation and job impact. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-15T14:50:47.760000-04:00
1551297 RED+BLUE STRATEGIES 10cbfe31-0213-4615-be7f-b28600233df9 Q2 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2014 second_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negative impact peoples access to prescription medications through mail. Issues related to the practice of giving coupons for certain prescription medications.CMS call letter focused on changes in policies regarding mail order and pharmacy networks. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-15T14:52:48.620000-04:00
1551324 RED+BLUE STRATEGIES 408ebeea-7e0d-4263-b89f-6e356757ba07 Q2 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2014 second_quarter PHA Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act - focused on reinvigorating the pipeline for new antibiotics.Issues related to prescription drug abuse in the Medicare and Medicaid programs. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-15T15:03:58.377000-04:00
1551857 MR. GALEN RESER 0fcf7199-9590-4959-baed-84fd56e0dbb7 Q2 MR. GALEN RESER 401055978 PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) 2014 second_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, H.R. 2835, "Restoring Access to Medication Act of 2013." FDA's proposed changes to generic drug labeling. FDA's proposed Infant Formula regulations. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-15T17:47:51.267000-04:00
1551984 OREGON HEALTH & SCIENCE UNIVERSITY cc11589a-a6e9-41f7-91c5-8a84aa15ba4c Q2 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2014 second_quarter PHA 340b Drug Discount Program for safety net hospitals Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2014-07-15T21:17:04.537000-04:00
1552342 BLUECROSS BLUESHIELD OF TENNESSEE 4f9c1771-e5d4-4811-8af9-28c036120613 Q2 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2014 second_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2014-07-16T10:39:22.580000-04:00
1552582 NOVO NORDISK INC. 1ade9b5c-7aa7-42e4-9171-7316ad2ca7f1 Q2 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2014 second_quarter PHA HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA)   440000 0 0 2014-07-16T12:08:28.423000-04:00
1552824 CHRISTY ELLERBEE CONSULTING, LLC efb665c6-67a8-4b91-bb4b-24ebada1ad86 Q2 CHRISTY ELLERBEE CONSULTING, LLC 401103332 INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.) 2014 second_quarter PHA Educating on Medically assisted treatment (MAT) within the opioid addiction disease space. HOUSE OF REPRESENTATIVES     0 0 2014-07-16T13:17:47.043000-04:00
1552835 TAUZIN CONSULTANTS, LLC c8afa91e-25cf-4b6e-81a1-98e8fdb41028 Q2 TAUZIN CONSULTANTS, LLC 400671007 PILLGUARD MEDICATION DELIVERY SYSTEMS 2014 second_quarter PHA Building awareness of and support for the PillGuard Medication Delivery System as a tool for medication adherence and prescription drug abuse prevention. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-07-16T13:19:49-04:00
1553154 ENDO INTERNATIONAL 17ba736e-4dc1-4095-b22d-1ce1853ff98b Q2 ENDO INTERNATIONAL 40011075 ENDO INTERNATIONAL 2014 second_quarter PHA Issues related to tamper resistant forumulation of pharmaceutical drugs; Life Sciences Jobs and Investment Act. HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2014-07-16T14:58:50.430000-04:00
1553369 KENT & O'CONNOR, INC. a5916306-6971-4b95-a9eb-a9bb881430e6 Q2 KENT & O'CONNOR, INC. 21426 INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION 2014 second_quarter PHA Legislation and regulations relating to drug safety issues. Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection 30000   0 0 2014-07-16T15:46:26.230000-04:00
1553436 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 7ec6f405-fb93-46f4-aebd-153846ba3293 Q2 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2014 second_quarter PHA S.644- The Preventing Abuse of Cough Treatments of Acts of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; H.R. 1188- The Preserving of Hometown Independent Pharmacies Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014;H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013 Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   450000 0 0 2014-07-16T15:59:28.417000-04:00
1553617 ANIMAL HEALTH INSTITUTE f6cc510f-2f5f-4b02-a0ad-8f46c7fa15e0 Q2 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2014 second_quarter PHA Issues related to illegal drug manufacturing under the guise of compounding. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2014-07-16T16:34:25.203000-04:00
1553968 EXPRESS SCRIPTS, INC. dd90a8a5-2e66-47a7-8724-736ffcc7b216 Q2 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2014 second_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Personnel Management (OPM),SENATE,White House Office   550000 0 0 2014-07-16T18:09:32.257000-04:00
1554004 VENABLE LLP 9066f758-044f-4e67-b60d-40140c585571 Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2014 second_quarter PHA Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs; issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act; Issues relating to Medicare Part D rebates; H.R. 486 Stop Tampering of Prescription Pills Act of 2013; H.R. 1919 Safeguarding Americas Pharmaceuticals Act of 2013 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-16T18:13:49.103000-04:00
1554931 ELI LILLY AND COMPANY 6f68f65e-ea6f-4933-ba72-cfa7ae8fe011 Q2 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2014 second_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1910000 0 0 2014-07-17T10:59:16.323000-04:00
1555484 GREATER NEW YORK HOSPITAL ASSOCIATION 41741d4e-b494-46f6-880d-ce69ea2795e2 Q2 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2014 second_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance and regulatory risk-based framework (FDA-2011-D-0530 and FDA-2014-N-0339); regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); ongoing pharmaceutical issues pertaining to drug shortages and significant price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); maximum allowable cost price transparency (CMS-4159-P). Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),SENATE,White House Office   280000 0 0 2014-07-17T12:06:35.013000-04:00
1555489 WHITMER & WORRALL, LLC dd8b1e9b-1da6-4f35-bee3-867e50782675 Q2 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2014 second_quarter PHA Issues related to monitoring healthcare reform. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) 30000   0 0 2014-07-17T12:09:26.750000-04:00
1555743 NATIONAL ASSOCIATION OF CHAIN DRUG STORES ace5f46a-af96-4a79-a0ec-65538f9189f5 Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2014 second_quarter PHA S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   640000 0 0 2014-07-17T12:52:06.907000-04:00
1555746 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 4a2a221a-abbf-4ae1-a0ca-0c8933b48c72 Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2014 second_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act. Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2014-07-17T12:53:33.483000-04:00
1555830 FTI GOVERNMENT AFFAIRS a3cc922f-79ea-409d-a421-8ed011623d70 Q2 FTI GOVERNMENT AFFAIRS 401054971 AMERICAS HEALTH INSURANCE PLANS (AHIP) 2014 second_quarter PHA H.R. 460, Patients' Access to Treatments Act (McKinley) - cost sharing in a specialty drug tier. H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs. H.R. 3204, Drug Quality and Security Act (Upton) - drug safety issues. S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-17T13:09:25.093000-04:00
1555835 VORYS ADVISORS, LLC b5d5e7e0-9f40-4d83-86ad-7cc96d48adc4 Q2 VORYS ADVISORS, LLC 400873558 AMERISOURCEBERGEN CORPORATION 2014 second_quarter PHA Various health care proposals. HOUSE OF REPRESENTATIVES     0 0 2014-07-17T13:09:51.107000-04:00
1556009 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) c54d20a9-2517-4d76-a6d1-691f6b78da06 Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2014 second_quarter PHA Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   233000 0 0 2014-07-17T13:59:05.953000-04:00
1556109 AMERICAN PHARMACISTS ASSOCIATION 8f22a3f2-d6b6-448a-a55b-0e3ff44c27fe Q2 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2014 second_quarter PHA HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-07-17T14:14:10.763000-04:00
1556249 THE DUBERSTEIN GROUP INC. 9a81069d-bc55-4bc8-826c-348b57861170 Q2 THE DUBERSTEIN GROUP INC. 12675 PHRMA INC. 2014 second_quarter PHA Agriculture appropriations re drug reimportation - HR 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015; S 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. HOUSE OF REPRESENTATIVES 100000   0 0 2014-07-17T14:38:46.047000-04:00
1557489 FTI GOVERNMENT AFFAIRS 7062ac82-9efc-48fb-8a4a-edd6ed660c3b Q2 FTI GOVERNMENT AFFAIRS 401054971 PERRIGO, INC. 2014 second_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, H.R. 2835, "Restoring Access to Medication Act of 2013." FDA's proposed changes to generic drug labeling. FDA's proposed Infant Formula regulations. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-17T16:54:09.997000-04:00
1557562 TCH GROUP, LLC eb7f2a66-f350-42ec-b943-213b365daf29 Q2 TCH GROUP, LLC 51478 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2014 second_quarter PHA General issues related to the 340B Federal Drug Pricing Program HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-07-17T17:08:04.153000-04:00
1558104 APOTEX CORP. 6d1a8c28-a1b0-4317-9c6a-abb8f2e1155d Q2 APOTEX CORP. 310973 APOTEX CORP. 2014 second_quarter PHA FDA proposed rule,Supplemental Applications Proposing Labeling Changes For Approved Drugs And Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes;Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics; Federal policy relating to issues affecting the generic drug industry within the House Energy and Commerce Committee's 21st Century Cures initiative, and; Federal policy relating to International Nonroprietary Names for Biosimilars Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   160000 0 0 2014-07-18T08:28:08.857000-04:00
1558133 THORSEN FRENCH ADVOCACY LLC df8ccd6d-8d97-4155-bcaa-0c6983bcdfe8 Q2 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2014 second_quarter PHA Issues related to access to pharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-18T08:43:15.060000-04:00
1558140 ALKERMES, INC. c05aa05b-e284-4fc7-9766-cb833bd8b616 Q2 ALKERMES, INC. 400458235 ALKERMES, INC. 2014 second_quarter PHA DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute on Alcohol Abuse & Alcoholism (NIAA),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE   553600 0 0 2014-07-18T08:46:16.857000-04:00
1558281 AMERICAN VETERINARY MEDICAL ASSOCIATION cdb46562-4d67-4bb1-a15b-1b1055e0b889 Q2 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2014 second_quarter PHA H.R. 1150, Preservation of Antibiotics for Medical Treatment Act S. 1256, Preventing Antibiotic Resistance Act, H.R. 1528/S. 1171, Veterinary Medicine Mobility Act, H.R. 4023 Fairness to Pet Owners Act, Animal Compounding, Veterinary Feed Directive Discussions with Congressional staff about DEA regulations impeding practice of veterinary medicine; seeking passage oflegislation to change underlying statute (H.R. 1528) Discussions with Congressional staff, FDA and USDA regarding the use of antimicrobials in food-producing animals, particularly with respect to H.R. 1150, (Preseravtion of Antibiotics for Medical Treatment Act) and S. 1256, (Preventing Antibiotic Resistance Act) Discussions with Congressional staff and FDA expressing the need for compounding of medications for use in animals. Inquiries to and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions, particularly regarding H.R. 4023, (Fairness to Pet Owners Act) Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2014-07-18T09:47:50.230000-04:00
1558405 TARPLIN, DOWNS & YOUNG, LLC 4a6a1455-795e-412d-a298-3ffba68518ba Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2014 second_quarter PHA **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation S. 10, S. 954 - Agriculture Reform, Food, and Jobs Act of 2013 H.R. 2186 - Valid Compounding Act H.R. 3204 The Drug Quality and Security Act, implementation H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies, user fee sequester, 21st Century Cures Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2014-07-18T10:06:37.667000-04:00
1558572 TARPLIN, DOWNS & YOUNG, LLC ddd8851f-f4db-4c22-90be-e0209e43f46b Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2014 second_quarter PHA **see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2437), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2014-07-18T10:22:23.293000-04:00
1558682 WILLIAMS AND JENSEN, PLLC 5e16ff66-3881-4ad7-9618-822eef19eea8 Q2 WILLIAMS AND JENSEN, PLLC 41454 PHARMACY SERVICES 2014 second_quarter PHA Regulations of compounding pharmacies. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-18T10:31:57.747000-04:00
1558804 TARPLIN, DOWNS & YOUNG, LLC 5c9f9130-5eba-4fc9-ab7e-37870fad0cad Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2014 second_quarter PHA **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 2186 - Valid Compounding Act H.R. 3204 The Drug Quality and Security Act, implementation H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee sequester relief, 21st Century Cures Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-18T10:47:45.217000-04:00
1558843 TARPLIN, DOWNS & YOUNG, LLC 00d22196-7dc1-40a2-a9cc-0994a8c59210 Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2014 second_quarter PHA **see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 2186 - Valid Compounding Act H.R. 3204 The Drug Quality and Security Act, implementation H.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester, 21st Century Cures Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2014-07-18T10:52:56.557000-04:00
1559617 NAHIGIAN STRATEGIES, LLC b67fbab2-87bc-4eb3-ba42-88fe22282461 Q2 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2014 second_quarter PHA Prescription drug misuse HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-18T11:42:58.230000-04:00
1559619 MCKENNA, LONG & ALDRIDGE 86752ca1-1c33-4f67-ac00-aa9cb87ee294 Q2 MCKENNA, LONG & ALDRIDGE 76913 PURDUE PHARMA 2014 second_quarter PHA U.S. and Canadian regulatory policies regarding prescription drug abuse. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-07-18T11:42:59.307000-04:00
1559841 EMPIRE CONSULTING GROUP c8211df9-8087-4a23-80cf-3791bf42e47a Q2 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2014 second_quarter PHA Issues relating to the Medicare Prescription Drug Act; budgetary issues pertaining to Medicare Part D; issues relating to a report on clinical trials and minority communities; 340B Drug Pricing Program; and possible amendments to agriculture appropriations legislation relating to pharmaceuticals. HOUSE OF REPRESENTATIVES 40000   0 0 2014-07-18T12:04:07.887000-04:00
1559903 KOUNTOUPES DENHAM CARR & REID, LLC d85cf3e6-cf75-434c-97fc-3a5882df1869 Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2014 second_quarter PHA General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic track- ing system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. FDA Review of the Over the Counter Review Monograph and related rulemaking; H.R.4502 Stop Meth Labs and Enhance Patient Access Act of 2014. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 50000   0 0 2014-07-18T12:10:29.810000-04:00
1560154 AMERICAN HORSE COUNCIL dd2de195-c05b-4189-a3ae-1a5666f3ee71 Q2 AMERICAN HORSE COUNCIL 2560 AMERICAN HORSE COUNCIL 2014 second_quarter PHA In support of the Veterinary Medicine Mobility Act of 2013 (H.R.1528) HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2014-07-18T12:35:58.577000-04:00
1560208 BROWN RUDNICK LLP 861201e9-c907-4910-8de8-49c7eeed82fb Q2 BROWN RUDNICK LLP 287895 APOTEX CORPORATION 2014 second_quarter PHA Issues relating to Risk Evaluation and Mitigation Strategies; Drug Quality and Security Act ( P.L. 113-54); FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (RIN:0910-AG94). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-07-18T12:44:17.420000-04:00
1560281 ACADEMY OF MANAGED CARE PHARMACY de7f2e79-b2da-4730-b1bc-db1d50ffb060 Q2 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2014 second_quarter PHA Support for legislation (National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 - NAPSER) to reauthorize the controlled substance monitoring programs under the Public Health Service Act designed to foster the establishment of state-administered prescription drug monitoring programs (S 2529/HR 3528). Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   197000 0 0 2014-07-18T12:52:40.717000-04:00
1560286 BROWN RUDNICK LLP 70215a43-5d6e-4e3a-ad2c-8f6af03d9485 Q2 BROWN RUDNICK LLP 287895 HOSPIRA, INC. 2014 second_quarter PHA Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products) HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2014-07-18T12:54:42.920000-04:00
1560385 BROWN RUDNICK LLP 8ec647c1-28eb-4dd1-b695-72494193384f Q2 BROWN RUDNICK LLP 287895 PRIME THERAPEUTICS 2014 second_quarter PHA Issues relating to generic pharmaceutical utilization; HR 4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-07-18T13:05:14.123000-04:00
1560486 BROWN RUDNICK LLP 9de452b9-4bcf-4f31-a9cc-87845915a82e Q2 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2014 second_quarter PHA H.R. 4709 & HR. 4069-Ensuring Patient Access and Effective Drug Enforcement Act" HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-18T13:16:36.903000-04:00
1560514 BROWN RUDNICK LLP 48a728e5-3995-4e02-8d1f-3419e25ae292 Q2 BROWN RUDNICK LLP 287895 MEDTRONIC INC 2014 second_quarter PHA DEA regulation relating to dispensing of compounded controlled substances to practitioner Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,White House Office 20000   0 0 2014-07-18T13:22:46.610000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1734.174ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API